The US Onychomycosis Market is expected to reach high market figures by the end of the forecasted period and is expected to grow at a CAGR of 6.4%.
Onychomycosis is a fungal contamination of the toe or finger nails, which results in discoloration, thickening, and partition of the nails from the nail bed. Despite the fact that it is not life-threatening, onychomycosis which more often created by a dermatophyte constitutes a vital public wellbeing issue in view of its high prevalence and related morbidity. The disease can have certain negative results for patients, for example, torment, and can possibly undermine work and social lives.
Onychomycosis which is also known as fungal infection of the nail, for most of the patient’s it is a cosmetic issue rather than a medical disease, thus patients seek help from cosmetic specialist and ignore the medical attention the disease needs. Onychomycosis causes pain, emotional, social and occupational discomfort, and permanent damage to the nail which spreads the infection.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2535.
Onychomycosis is responsible for 50% to 60% of the nail disease and is classified into various types like Distal Subungal Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungal Onychomycosis (PSO), Total Dystrophic Onychomycosis (TDO), Endonyx Onychomycosis (EO).
There are other diseases which are known to damage the nail which include dermatophytes, molds and yeasts, but these diseases are not fungal from its source these diseases are caused by other medical conditions like work in wet conditions, trauma, HIV-AIDS, old age, psoriasis, atopic dermatitis among others.
The prevalence of onychomycosis is classified by disease type, by gender and by age. By prevalence in gender it is discovered that the male populations is more effected by this disease then the female population. Approximately 65% to 70% of the adult male population is prone to be affected by this disease compared to 30% to 35% of the adult female population.
Onychomycosis in children has been observed to be very less when compared to that of adults, prevalence rate in children is found out to be approximately 2% to 3% with comparison to adults who are more than 40 years having a prevalence rate in the range of 7-10%.
Key Players for Onychomycosis Market:
Some of the key players in this market are: Anacor Pharmaceuticals, Johnson and Johnson, Novartis, Valeant Pharmaceuticals
Order Copy of 30 Premium Pages is Available @ https://www.marketresearchfuture.com/order_form.pdf?report_id=2535 .
Regional Analysis of Onychomycosis Market:
The US market for Onychomycosis is expected to grow at a CAGR of 6.4% and is expected to reach at more than US$ 5 billion by the end of the forecasted period. This is due to increasing ageing populations.
- North America
List of Tables
Table 1 Table for Identifying Types of Onychomycosis
Table 2 Us Onychomycosis Market, By Types Us$ (Million)
Table 3 Us Nail Care Market, By Major Drugs Us$(Million)
Table 4 Us Jublia Drug Market, By Value Us$(Million)
Table 5 Us Jublia Drug Market, By Asp ($)
Table 6 Us Jublia Drug Market by Volume
Table 7 Us Kerydin Drug Market By Value Us$ (Million)
Table 8 Us Kerydin Drug Market, By Asp ($)
Table 9 Us Kerydin Drug Market by Volume
Table 10 Us Generic Drug Market By Value Us$ (Billion)
Table 11 Us Onychomycosis Major Players: 2015 (% Share)
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/2535 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –